about
Cost-effectiveness of noninvasive liver fibrosis tests for treatment decisions in patients with chronic hepatitis C.Estimating utility data from clinical indicators for patients with stable angina.Exploring what lies behind public preferences for avoiding health losses caused by lapses in healthcare safety and patient lifestyle choicesUse of generic and condition-specific measures of health-related quality of life in NICE decision-making: a systematic review, statistical modelling and survey.A review of generic preference-based measures of health-related quality of life in visual disordersBinary choice health state valuation and mode of administration: head-to-head comparison of online and CAPIWhen does NICE recommend the use of health technologies within a programme of evidence development? : a systematic review of NICE guidanceAn assessment of validity and responsiveness of generic measures of health-related quality of life in hearing impairment.Utility values in National Institute for Health and Clinical Excellence (NICE) Technology Appraisals.Bridging the gap between methods research and the needs of policy makers: a review of the research priorities of the National Institute for Health and Clinical Excellence.Evaluation of content on EQ-5D as compared to disease-specific utility measures.Informing a decision framework for when NICE should recommend the use of health technologies only in the context of an appropriately designed programme of evidence development.Mapping to obtain EQ-5D utility values for use in NICE health technology assessments.Preparatory study for the revaluation of the EQ-5D tariff: methodology report.Investigating women's preferences for intrapartum care: home versus hospital births.An Empirical Study of Two Alternative Comparators for Use in Time Trade-Off Studies.An assessment of the impact of informative dropout and nonresponse in measuring health-related quality of life using the EuroQol (EQ-5D) descriptive system.Survival gain after liver transplantation for patients with alcoholic liver disease: a comparison across models and centers.Women and health care professionals' preferences for Down's Syndrome screening tests: a conjoint analysis study.An empirical comparison of EQ-5D and SF-6D in liver transplant patients.Midterm cost-effectiveness of the liver transplantation program of England and Wales for three disease groups.Valuing Health Using Time Trade-Off and Discrete Choice Experiment Methods: Does Dimension Order Impact on Health State Values?Mapping the FACT-P to the preference-based EQ-5D questionnaire in metastatic castration-resistant prostate cancer.Assessing health-related quality of life pre- and post-liver transplantation: a prospective multicenter study.Measuring health-related utility: why the disparity between EQ-5D and SF-6D?An economic evaluation of pediatric small bowel transplantation in the United Kingdom.Comparison of general practitioner records and patient self-report questionnaires for estimation of costsCost-effectiveness of upcoming treatments for hepatitis C: We need to get the models rightDoes Responsibility Affect the Public's Valuation of Health Care Interventions? A Relative Valuation Approach to Health Care SafetyNICE Methodology for Technology AppraisalsDetermining Priority for Liver TransplantationElicitation of Health-Related Utility in Perianal Fistula in Crohn's Disease
P50
Q30422586-C243CA5F-079F-4680-BC4D-98A36FA8A9EEQ33224199-4D5695BC-B46A-4FB2-84DB-8B58CD018210Q34790317-37FF0F6B-3BE4-448E-B955-5D6A3DA3786FQ35093921-EFB89AE6-A056-4E16-9F76-CFA8414EC8B4Q35713188-41A1D986-897C-4B80-983D-CE59145BC2AFQ36567135-248347BA-0EF6-4EFC-9308-0CA091BA0793Q36579754-65D7E63C-DD14-414E-B572-25B9A1CE2359Q37369035-06DCB5CA-8A54-4C15-AD98-F68FA0DBEA81Q37826471-3C0E7309-38C9-41B9-94F5-A5F48B0FC14CQ37859117-6F76117C-3F21-4787-97BF-279E133F93C6Q38021389-201D4058-DEEA-48FF-9EB8-95D89450F4CFQ38062188-448F68CB-9549-41BC-8891-FBC1E2216486Q38075670-D0770963-AD05-434D-AB59-8B4E937AC2E2Q39279904-C72F79F5-BAB5-448D-AE51-C9E39127E405Q39410362-A80A9108-6083-45A6-AED9-03E5878CDA00Q40076158-CF021106-82AE-4292-B2A7-162E07A5C822Q40429274-A7AA8115-93E6-4AF8-909F-01CD8A8F1762Q44681428-EA0C9C09-588B-433C-8EC4-CECF2051F7C9Q47307138-31DC0BCE-369F-48FD-AE76-F92C67A06348Q47321989-0DC4EEE6-E4B8-4F54-ACF6-D9E5D2A58547Q47376686-C6092274-1FE4-41FD-87E1-02B7B3F18055Q47788121-D03CB755-C50A-43B1-9C0E-991CE7741692Q48082839-9521DEBE-D8B8-4CF7-8A2B-F267E05852CBQ51958747-923DA03B-96B4-4621-93B6-812DDC84FF75Q51971105-362C2890-0D2F-4B0E-99DB-8B50F1F33FD5Q53008977-CF19D737-EF04-4219-A325-46EE6821E197Q57208207-0014FF0A-6ABA-41C2-AB3F-F82A3BBFD7CDQ57809232-9F1E2155-E7B6-466E-8A5C-6CB0367F324AQ57809258-E68D08D3-DB6A-438F-8694-D97DD776A38AQ57809269-2A4CF756-6B84-440D-A233-10EF2C3BB521Q57809283-D065F231-C8FE-4F10-8998-3B3E8173BC5AQ90575525-9AAED6EB-5E8C-41DA-9C93-22E30C754AF2
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Louise J Longworth
@nl
Louise J Longworth
@sl
Louise J. Longworth
@en
Louise J. Longworth
@es
type
label
Louise J Longworth
@nl
Louise J Longworth
@sl
Louise J. Longworth
@en
Louise J. Longworth
@es
prefLabel
Louise J Longworth
@nl
Louise J Longworth
@sl
Louise J. Longworth
@en
Louise J. Longworth
@es
P106
P1153
6602368778
P21
P31
P496
0000-0003-2512-4862